GENOME ANNOUNCEMENT {#h0.0}
===================

*Propionibacterium acnes* is a Gram-positive bacterium constituting a significant part of the human skin microbiota ([@B1]). It has been associated with skin diseases such as acne vulgaris or fulminans acne ([@B2]). The role of this microorganism in deep and medical device-related infections is underestimated ([@B3]). Besides shoulder prosthetic infections, spinal instrumentation infections have been reported ([@B4]). Using multilocus sequence typing (MLST) and single-locus sequence typing (SLST) schemes, the *P. acnes* species has been subdivided into five main phylogenetic types: IA1, IA2, IB, IC, II, and III ([@B5], [@B6]). In the context of device-related infections, *P. acnes* antibiotic resistance may be a problem, especially when low- or high-level rifampin resistance is detected ([@B7], [@B8]), as rifampin remains a key drug for eradicating *P. acnes* biofilm infection ([@B9]).

Here, we present the draft genome sequences of four *P. acnes* strains (2003-1719, NTS31306190, 2004-10708, and LRY_BL) isolated from patients at Nantes University Hospital and La Roche/Yon Hospital, France, suffering from bone infection.

All *P. acnes* strains were grown overnight at 37°C on Schaedler agar plate (Oxoid, United Kingdom) under an anaerobic atmosphere. Genomic DNA was extracted using a DNeasy blood and tissue kit (Qiagen Gmbh, Germany) as described previously ([@B10]). A pair-end library was prepared with a NEBNext Ultra DNA library prep kit for Illumina (NEB) and sequenced (2 × 150 bp) on a MiSeq sequencer (Illumina, USA). *De novo* assembly was performed with Velvet version 1/2/10 and VelvetOptimizer version 2.2.5 (optimal hash value = 127). Contig reordering and annotation were performed with Mauve version 2.3.1 and the NCBI Prokaryotic Genome Automatic Annotation Pipeline (PGAAP), respectively ([@B11], [@B12]). Sequence alignment and comparison were performed with CLC Sequence Viewer version 7.0 and BLAST. Average nucleotide identity (ANI) with the *P. acnes* reference strain KPA171202 was calculated using Oat version 0.91 ([@B13]).

The draft genome of strain NTS_2003_1719 (GenBank accession no. MAVU00000000) contains 2,373 genes, 2,320 coding sequences (CDSs), 46 tRNAs, 3 rRNAs, and 4 noncoding RNAs, with an OrthoANI value of 99.1%; the draft genome of strain NTS_31306190 (accession no. MAUY00000000) contains 2,327 genes, 2,275 CDSs, 45 tRNAs, 3 rRNAs, and 4 noncoding RNAs, with an OrthoANI value of 99.1%; the draft genome of strain NTS_2004_10708 (accession no. MAUW00000000) contains 2,322 genes, 2,270 CDSs, 45 tRNAs, 3 rRNAs, and 4 noncoding RNAs, with an OrthoANI value of 99.0%; the draft genome of strain LRY_BL (accession no. MAUX00000000) contains 2,376 genes, 2,327 CDSs, 45 tRNAs, 0 rRNAs, and 4 noncoding RNAs, with an OrthoANI value of 100.0% ([Table 1](#tab1){ref-type="table"}).

###### 

Summary of genome sequencing results in the present study

  *P. acnes* strain   Clinical source   Reads (Mb)   Coverage (×)   No. of contigs   Size (bp)   G+C content (%)   OrthoANI value[^a^](#ngtab1.1){ref-type="table-fn"} (%)   Accession no.                                                       BioProject designation   SLST   MLST   Phylotype
  ------------------- ----------------- ------------ -------------- ---------------- ----------- ----------------- --------------------------------------------------------- ------------------------------------------------------------------- ------------------------ ------ ------ -----------
  NTS_2003_1719       Spine material    3,807,168    186            19               2,535,892   60.1              99.1                                                      [MAVU00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAVU00000000)   PRJNA327922              D1     ST27   IB
  NTS_31306190        Knee prosthesis   3,301,044    127            20               2,479,585   60.0              99.1                                                      [MAUY00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAUY00000000)   PRJNA327858              A1     ST18   IA
  NTS_2004_10708      Spine material    2,928,004    131            17               2,478,327   60.1              99.0                                                      [MAUW00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAUW00000000)   PRJNA327854              A26    ST18   IA
  LRY_BL              Hip prosthesis    2,735,728    49             32               2,534,633   60.0              100.0                                                     [MAUX00000000](https://www.ncbi.nlm.nih.gov/nuccore/MAUX00000000)   PRJNA327856              H1     ST36   IB

OrthoANI value compared to the *P. acnes* reference strain KPA171202.

According to the diversity of *Propionibacterium* spp. on human skin ([@B14]), their potential involvement in prosthetic-related infections remains an open question for future research. The genome sequences of these four strains of *P. acnes* will also provide a valuable resource for (comparative) bone cell--*P. acnes* host relationship studies. Indeed, depending on their genetic background, *P. acnes* cells seem to interact differently with the bone cell matrix (G. G. Aubin and S. Corvec, unpublished data). These draft genomes of *P. acnes* will also be used for studying virulence features associated with bone infection, especially hyaluronate lyase ([@B15]).

Accession number(s). {#s1}
--------------------

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession numbers listed in [Table 1](#tab1){ref-type="table"}. The versions described in this paper are in the first versions, under the BioProject designations listed in [Table 1](#tab1){ref-type="table"}.
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